Close

Analyst Ratings for BioMarin Pharmaceutical Inc. (bmrn)

bmrn Rating Summary

bmrn Price Target Summary

* Over Last 12-Mos
  |   Expand Research on bmrn
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $109.42 (+22.1%) * Over Last 12-Mos
Rating Score: 7 / 10   Percentile Rank: 75%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/16/2024 Truist Securities Joon Lee New Coverage Buy
(N/A)
140.00
(N/A)
92.22
(89.58)
-2.86% Details
11/15/2023 Wells Fargo N/A New Coverage Overweight
(N/A)
100.00
(N/A)
84.86
(89.58)
5.56% Details